CWM
AGN

Cabot Wealth Management’s Allergan plc AGN Stock Holding History

Cabot Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,480
Closed -$3.04M – 152
2016
Q4 		$3.04M Sell
14,480
-5,465
-27% -$1.13M 0.82% 43
2016
Q3 		$4.59M Sell
19,945
-226
-1% -$55.2K 1.18% 29
2016
Q2 		$4.66M Sell
20,171
-550
-3% -$127K 1.23% 28
2016
Q1 		$5.55M Sell
20,721
-382
-2% -$109K 1.55% 19
2015
Q4 		$6.59M Sell
21,103
-538
-2% -$160K 1.69% 14
2015
Q3 		$5.88M Sell
21,641
-186
-0.9% -$57.1K 1.62% 13
2015
Q2 		$6.62M Buy
21,827
+395
+2% +$118K 1.61% 12
2015
Q1 		$6.38M Buy
21,432
+1,035
+5% +$295K 1.55% 14
2014
Q4 		$5.25M Sell
20,397
-1,976
-9% -$494K 1.3% 24
2014
Q3 		$5.4M Sell
22,373
-38
-0.2% -$8.5K 1.38% 16
2014
Q2 		$5M Buy
22,411
+196
+0.9% +$40.6K 1.26% 25
2014
Q1 		$4.57M Buy
22,215
+7,236
+48% +$1.43M 1.2% 29
2013
Q4 		$2.52M Buy
14,979
+190
+1% +$29.7K 0.66% 74
2013
Q3 		$2.13M Sell
14,789
-234
-2% -$31.2K 0.64% 79
2013
Q2 		$1.9M Buy
+15,023
New +$1.7M 0.65% 66

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cabot Wealth Management's AGN Position: Q1 2017 in Review

Cabot Wealth Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 14,480 shares — an estimated $3.04M sold.

Cabot Wealth Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $6.62M in Q2 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Cabot Wealth Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Cabot Wealth Management sold 14,480 Allergan plc shares in Q1 2017, an estimated $3.04M.
  • Cabot Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Cabot Wealth Management's Allergan plc position peaked at $6.62M in Q2 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Cabot Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.